Skip to main content

Table 1 Clinical and demographic characteristics of the patient cohort

From: Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort

Characteristic

All patients

Patients with lung metastasis

Patients without lung metastasis

Patients with lung-only metastasis

N = 129,143

N = 6977

N = 122,166

N = 1065

Age

 < 65

63,024 (48.8)

3724 (53.4)

59,300 (48.5)

479 (45.0)

 ≥ 65

66,119 (51.2)

3253 (46.6)

62,866 (51.5)

586 (55.0)

Race

 White

100,788 (78.0)

5124 (73.4)

95,664 (78.3)

798 (74.9)

 Black

15,650 (12.2)

1101 (15.8)

14,549 (11.9)

159 (14.9)

 Others

12,705 (9.8)

752 (10.8)

11,953 (9.8)

108 (10.2)

Gender

 Female

61,569 (47.7)

3146 (45.1)

58,423 (47.8)

518 (48.6)

 Male

67,574 (52.3)

3831 (54.9)

63,743 (52.2)

547 (51.4)

Grade

 Grade I

10,168 (7.9)

313 (4.5)

9855 (8.1)

51 (4.8)

 Grade II

84,526 (65.5)

3715 (53.2)

80,811 (66.1)

626 (58.8)

 Grade III

19,129 (14.8)

1034 (14.8)

18,095 (14.8)

140 (13.1)

 Grade IV

3679 (2.8)

171 (2.5)

3508 (2.9)

23 (2.2)

 Unknown

11,641 (9.0)

1744 (25.0)

9897 (8.1)

225 (21.1)

AJCC TNM stage

 I

30,460 (23.6)

0 (0.0)

30,460 (24.9)

0 (0.0)

 II

33,081 (25.6)

0 (0.0)

33,081 (27.1)

0 (0.0)

 III

37,915 (29.4)

0 (0.0)

37,915 (31.0)

0 (0.0)

 IV

27,687 (21.4)

6977 (100.0)

20,710 (17.0)

1065 (100.0)

AJCC T stage

 T0

56 (0.0)

9 (0.1)

47 (0.0)

3 (0.3)

 T1

22,947 (17.8)

904 (13.0)

22,043 (18.0)

125 (11.7)

 T2

16,173 (12.5)

130 (1.9)

16,043 (13.2)

37 (3.5)

 T3

62,061 (48.1)

2028 (29.0)

60,033 (49.1)

492 (46.2)

 T4

21,021 (16.3)

1606 (23.0)

19,415 (15.9)

242 (22.7)

 TX

6885 (5.3)

2300 (33.0)

4585 (3.8)

166 (15.6)

AJCC N stage

 N0

71,956 (55.7)

2317 (33.2)

69,639 (57.0)

471 (44.2)

 N1

35,029 (27.2)

2369 (34.0)

32,660 (26.7)

394 (37.0)

 N2

19,388 (15.0)

1293 (18.5)

18,095 (14.8)

200 (18.8)

 N3

2770 (2.1)

998 (14.3)

1772 (1.5)

0 (0.0)

AJCC M stage

 M0

101,456 (78.6)

0 (0)

101,456 (83.0)

0 (0.0)

 M1

27,687 (21.4)

6977 (100.0)

20,710 (17.0)

1065 (100.0)

Marital status

 Married

67,504 (52.3)

3299 (47.3)

64,205 (52.6)

489 (45.9)

 Single

53,026 (41.0)

3203 (45.9)

49,823 (40.8)

521 (48.9)

 Unknown

8613 (6.7)

475 (6.8)

8138 (6.6)

55 (5.2)

Insurance status

 Insured

84,167 (65.2)

4002 (57.4)

80,165 (65.6)

1006 (94.5)

 Uninsured

4693 (3.6)

401 (5.7)

4292 (3.5)

45 (4.2)

 Unknown

40,283 (31.2)

2574 (36.9)

37,709 (30.9)

14 (1.3)

Chemotherapy

 Yes

57,583 (44.6)

4700 (67.4)

52,883 (43.3)

730 (68.5)

 No/Unknown

71,560 (55.4)

2277 (32.6)

69,283 (56.7)

335 (31.5)

Site

 Right-sided colon

52,861 (40.9)

2168 (31.1)

50,693 (41.5)

304 (28.5)

 Left-sided colon

36,085 (27.9)

1854 (26.6)

34,231 (28.0)

219 (20.6)

 Rectum

29,231 (22.6)

2165 (31.0)

27,066 (22.2)

431 (40.5)

 Rectosigmoid

10,966 (8.6)

790 (11.3)

10,176 (8.3)

111 (10.4)

Surgery

 No

16,789 (13.0)

4305 (61.7)

12,461 (10.2)

475 (44.6)

 Yes

111,450 (86.3)

2595 (37.2)

108,850 (89.1)

586 (55.0)

 Unknown

904 (0.7)

77 (1.1)

855 (0.7)

4 (0.4)

Radiotherapy

 Yes

21,396 (16.6)

1164 (16.7)

20,232 (16.6)

267 (25.1)

 No/Unknown

107,747 (83.4)

5813 (83.3)

101,934 (83.4)

798 (74.9)

Osseous metastasis

   

–

 No

127,287 (98.6)

6107 (87.6)

121,180 (99.2)

 

 Yes

1511 (1.1)

672 (9.6)

839 (0.7)

 

 Unknown

345 (0.3)

198 (2.8)

147 (0.1)

 

Brain metastasis

   

–

 No

128,368 (99.4)

6564 (94.0)

121,804 (99.8)

 

 Yes

367 (0.3)

185 (2.7)

182 (0.1)

 

 Unknown

408 (0.3)

228 (3.3)

180 (0.1)

 

Liver metastasis

   

–

 No

108,363 (83.9)

1892 (27.2)

106,471 (87.2)

 

 Yes

20,641 (16.0)

5019 (71.9)

15,622 (12.7)

 

 Unknown

139 (0.1)

66 (0.9)

73 (0.1)

Â